The NCCN recommends that breast cancer screening for BRCA1- and BRCA2-mutation carriers should include annual mammography and clinical breast examination every 6–12 months, starting at age 25 or individualized based on one's family history [52]. This evidence concerns the gene BRCA2 and breast carcinoma.